文献速递骨质疏松与代谢性骨病

四肢瘦体质量与骨折风险评估:对FRAX®及肌少症的意义

Appendicular lean mass and fracture risk assessment: implications for FRAX® and sarcopenia.
PubMed 文献 · Osteoporos Int · 2019-02-27

本文为社论,指出DXA测得的四肢瘦体质量(ALM)对偶发骨折的预测能力有限,在美国MrOS、WHI和Health ABC队列中,校正股骨颈骨密度后ALM与骨折的关联可能完全消失。作者结论认为DXA ALM不太可能成为FRAX工具的有用补充,而肌酸稀释法或外周定量CT等其他估算肌肉质量的方法可能对骨折风险评估更有价值。

要点

  • 当前大多数肌少症定义使用DXA衍生的四肢瘦体质量(ALM)近似代表肌肉质量。
  • 美国MrOS、WHI和Health ABC队列中,校正股骨颈骨密度后ALM与骨折的关联可能完全消失。
  • 作者认为DXA ALM不太可能成为FRAX工具的有用补充。

核心结论

  • DXA ALM不太可能成为FRAX工具的有用补充,而肌酸稀释法或外周定量CT等其他估算肌肉质量的方法可能对骨折风险评估更有价值。

研究设计与样本

  • 本文为社论,描述来自数个队列的研究发现,涉及美国MrOS、WHI和Health ABC队列。

主要发现

  • 越来越多的证据表明ALM对偶发骨折的预测能力较差。
  • 在美国MrOS、WHI和Health ABC队列中,校正股骨颈骨密度后ALM与骨折的关联可能完全消失。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The vast majority of current sarcopenia definitions use DXA-derived appendicular lean mass (DXA ALM) as an approximation of muscle mass. However, there is increasing evidence that ALM is poorly predictive of incident fractures. In this editorial, we describe findings from several cohorts suggesting that DXA ALM gives only limited information on the risk of incident fracture, and that in the US MrOS, WHI and Health ABC cohorts, accounting for femoral neck bone mineral density may entirely remove ALM-fracture associations. These observations raise important questions about the role of DXA ALM both in sarcopenia definitions and as a potential input variable for FRAX. We conclude that DXA ALM is unlikely to be a useful addition to the FRAX tool, but that other means of estimating muscle mass, such as those derived from creatine dilution or peripheral quantitative CT, might offer more value for fracture risk assessment.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Harvey NC, Kanis JA, Liu E, et al. Appendicular lean mass and fracture risk assessment: implications for FRAX® and sarcopenia. Osteoporos Int. 2019. PMID: 30815717. doi:10.1007/s00198-019-04904-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。